Skip to content
  • Saturday, 15 August 2026
  • 12:26 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Tubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s Diseases
Neuroscience & Brain Research

Tubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s Diseases

Rifan Muazin Jul 7, 2026 0

Scientists at the Baylor College of Medicine have announced a landmark discovery in the field of neurobiology, identifying a novel…

Read More
Neuroscience & Brain Research

Baylor College of Medicine Researchers Identify Tubulin as a Key Protective Factor Against Alzheimer’s and Parkinson’s Disease Pathogenesis

Rifan Muazin Jun 29, 2026 0

In a landmark study that may redefine the therapeutic landscape for neurodegenerative disorders, scientists at Baylor College of Medicine have…

Read More
Neuroscience & Brain Research

Tubulin Acts as a Molecular Chaperone to Prevent Toxic Protein Aggregation in Alzheimer’s and Parkinson’s Disease Research

Rifan Muazin Jun 21, 2026 0

Scientists at the Baylor College of Medicine have announced a significant breakthrough in the understanding of neurodegenerative pathologies, identifying a…

Read More
Psilocybin Induces Lasting Brain Connectivity Changes and Psychological Insight According to New UCSF and Imperial College London StudyStanford University Researchers Identify Glucose as a Master Regulator of Tissue Differentiation Beyond Its Role as a Primary Energy SourceBreakthrough in PFAS Degradation Scientists Identify Hydrogen Radicals as Key to Destroying Forever Chemicals Using UV LightMerative MarketScan Podcast Launches Season Two Exploring Real-World Healthcare Costs
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ